Trial intelligence / Profile preview

Acetyl L-carnitine versus mecobalamin for diabetic peripheral neuropathy

ChiCTR-TRC-08000141Phase 2Completed

Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Start
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of acetyl-l-carnitine in diabetic polyneuropathy (DPN) (2 arms), sponsored by Haisco Pharmaceutical Group Co., Ltd. Primary endpoint: Change in NSS/NDS score. Started Jul 2008; status: completed.

02

Drugs

acetyl-l-carnitine
03

Conditions

diabetic polyneuropathy (DPN)

Beyond the preview

Go deeper on ChiCTR-TRC-08000141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-08000141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call